Please login to the form below

Not currently logged in
Email:
Password:

KCR relocates head office from Warsaw to Berlin

Polish contract research organisation opens newbase in Germany

KCR contract research organisation (CRO) Berlin office

Polish contract research organisation KCR has relocated its head office from Warsaw to Berlin in a move it said would allow it to better serve its customers.

The CRO, whose new base will be in Mitte [pictured] - the historical centre of the German capital, also expects its new location to aid the expansion of its services and operations.

Mike Jagielski, KCR's president and CEO, said: "This is an important step to further implement KCR's business growth strategy. The establishment of a new head office in Berlin builds upon our previous decisions on strengthening the company's footprint in Western Europe.

“Moving to Germany is a response to our clients' expectations regarding KCR's strong presence in Western Europe. It will also allow us to further diversify the KCR talent pool to support our customer-focused approach.”

KCR's new Berlin head office will serve as its management and business development centre and the CRO's Warsaw office will continue to be run as its operational hub.

Article by
Dominic Tyer

11th March 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics